GUILFORD, Conn.–(BUSINESS WIRE)–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in B. Riley Securities’ Life Sciences Tools Conference – Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference to be held on Thursday, April 6, 2023. Patrick Schneider, Ph.D., Quantum-Si’s President and … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces enrollment of the first patient in the FORESEE clinical trial with the Company’s proprietary cerebrospinal fluid assay CNSide (NCT05414123). This first patient was seen at the UT Southwestern Medical Center, one of the largest and most respected hospitals … [Read more…]

Healthcare Private Equity Firm Builds for Growth with Renewed New York Presence NEW YORK–(BUSINESS WIRE)–Kain Capital LLC, a leading private equity firm focused on the technology enablement of healthcare services companies, today announced that it has moved into new office space at One World Trade Center in New York City. This marks the firm’s return … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Markets for Bioengineered Protein Drugs” report has been added to ResearchAndMarkets.com’s offering. The global bioengineered protein drugs market was estimated to have been worth $327.6 billion in 2021. Between 2022 and 2027, the bioengineered protein drugs market is predicted to grow at a compound annual growth rate (CAGR) of 8%, leading to … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Chemotherapy Induced Diarrhea – Epidemiology Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This “Chemotherapy-induced Diarrhea (CID) – Epidemiology Forecast – 2032” report delivers an in-depth understanding of the CID, historical and forecasted epidemiology as well as the CID market trends in the United States, EU4 (Germany, France, Italy, and Spain) … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Intrapartum Monitoring Devices Market 2023-2027” report has been added to ResearchAndMarkets.com’s offering. The intrapartum monitoring devices market is forecasted to grow by $970.11 mn during 2022-2027, accelerating at a CAGR of 6.36% during the forecast period. The report on the intrapartum monitoring devices market provides a holistic analysis, market size and forecast, … [Read more…]

LONDON–(BUSINESS WIRE)–Regulatory News: BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery and development company, announces the publication of the convening notice for its Annual General Meeting which will be held on 4 May 2023 at 14:00 CEST at 5 place Winston Churchill, L-1340 Luxembourg (the “AGM”). The convening notice, … [Read more…]

WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD) use in the treatment of certain types of myelofibrosis (MF), polycythemia vera (PV) and graft-versus-host disease (GVHD). The complete response letter states that the … [Read more…]

BROOMFIELD, Colo.–(BUSINESS WIRE)–Swisslog Healthcare, a leading supplier in transport automation and medication management solutions, has announced the promotion of Eric Waski to Senior Vice President of the North American Technology Center. Waski has been with the organization for nearly 26 years. Previously, Waski served as the Head of Operational Excellence based in the Colorado offices … [Read more…]

PORTLAND, Ore.–(BUSINESS WIRE)–In recognition of DVT Awareness Month, the Inovia Vein Specialty Centers have launched a community outreach campaign to raise awareness about Deep Vein Thrombosis (DVT) and encourage the public to become more aware of risks and to take preventative measures against this potentially life-threatening condition. “Deep Vein Thrombosis occurs when blood clots form … [Read more…]